Once the device data are read, the transmitter automatically transmits the information to the secure St. Jude Medical Patient Care Network Web site (merlin.net), where it can be viewed by the clinician. The EX1150 communicates with the remote-monitoring center via a telephone landline, cellular adapter, or broadband WiFi service.
Jun 12, 2011 A short video guide to setting up and using the Merin@home transmitter. Just karaoke user manual. This ships with the Merlin@home home monitoring box. Find many great new & used options and get the best deals for ZTE MF833V USB Adapter Wireless Modem Use With Merlin Home Transmitter Ex1151 at the best online prices at eBay! Free shipping for many products! N The wireless access point attaches to any Merlin@home transmitter enabling timely access to comprehensive data of the patient’s current disease state and implanted device status through the Merlin.net™ Patient Care Network (PCN) n The wireless access point is easy to install and use on new and existing Merlin@home transmitters. Jude Medical’s implantable cardiac devices that rely on the Merlin@home remote monitoring system are vulnerable to hacking. Recipients of affected St. Jude devices may be entitled to file a Merlin@home transmitter lawsuit to obtain compensation from the company.
ST.PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the U.S. launch of its Wireless USB Adaptor for the Merlin@home™ transmitter, a system that allows important patient data from an implantable cardiac device to be wirelessly downloaded and securely transmitted via telephone for review by a physician. The new Wireless USB Adaptor enables patients using a Merlin@home transmitter to transmit data to their physician over cellular networks, allowing for more convenient care than existing landline services provide.
“For patients who either prefer to use cellular technology or do not have access to a standard phone line, this product provides an alternative solution for secure data transmission,” said Dr. David Sandler, director of electrophysiology at the Oklahoma Heart Institute in Tulsa, Okla. “The Wireless USB Adaptor offers a reliable, portable remote monitoring option for patients who frequently travel.”
The Wireless USB Adaptor is a small device that plugs into new and existing Merlin@home transmitters. The transmitter typically sits on a patient’s bedside table and wirelessly communicates with the patient’s device while they are asleep. The data are sent via the Merlin@home transmitter to the Merlin.net™ Patient Care Network (PCN), an Internet-based repository of patient and device data. Once transmitted, the Merlin.net PCN organizes the data for fast analysis and easy review, and allows information to be sent directly to a clinic’s or hospital’s electronic health record (EHR) system for inclusion in the patient’s comprehensive EHR.
“This technology improves patient care by providing an efficient remote monitoring system when the use of a landline is inconvenient or unavailable,” said Eric S. Fain, M.D., president of the St. Jude Medical Cardiac Rhythm Management Division. “The Wireless USB Adaptor is another addition to our innovative product portfolio and demonstrates the strength of our connectivity platform.”
The remote monitoring capabilities facilitated by the Merlin@home transmitter permit automated follow-up appointments and daily device checks to occur wirelessly, with limited patient action required. This reduces unnecessary visits to the physician’s office, while allowing physicians to more quickly become aware of changes with the patient’s condition or device.
The transmitter supports all radio-frequency (RF) St. Jude Medical implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy defibrillators (CRT-Ds), and the Accent™ RF pacemaker and Anthem™ RF CRT-P (cardiac resynchronization therapy pacemaker). The Accent RF pacemaker and Anthem CRT-P are the first and only pacemakers that provide complete remote and in-clinic follow-ups via wireless communication.
Implantable cardiac devices are designed to capture and record information about device performance and patient heart rhythms that is vital to patient care. Alerts can also be set up by the physician, based on their preferences, notifying them of any important changes with the patient’s condition or device.
The data transferred using the Merlin@home device are fully encrypted and meet or exceed all applicable national data privacy and security requirements in every country where the Merlin.net PCN is used. In addition, BSI Management Systems, an international standards testing, registration and certification organization, has awarded St. Jude Medical the information security certification ISO/IEC 27001:2005. This ISO certification, a stringent worldwide information security standard, recognizes that the St. Jude Medical Merlin.net PCN has established processes and standards that maintain the strictest levels of confidentiality, integrity and availability for its customers. The Merlin.net PCN is the first medical device data network to be recognized with this certification.
The Merlin.net PCN was also recognized as a silver winner of the 2009 Medical Design Excellence Awards, an award competition that is organized and presented by Canon Communications LLC and is the only awards program that exclusively recognizes contributions and advances in the design of medical products.
About St. Jude Medical
St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. St. Jude Medical is headquartered in St. Paul, Minn., and has four major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. For more information, please visit sjm.com.
Forward-Looking Statements
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such forward-looking statements include the expectations, plans and prospects for the Company, including potential clinical successes, anticipated regulatory approvals and future product launches, and projected revenues, margins, earnings and market shares. The statements made by the Company are based upon management’s current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include market conditions and other factors beyond the Company’s control and the risk factors and other cautionary statements described in the Company’s filings with the SEC, including those described in the Risk Factors and Cautionary Statements sections of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended April 3, 2010. The Company does not intend to update these statements and undertakes no duty to any person to provide any such update under any circumstance.
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration (FDA) approval of the Merlin™@home transmitter, an RF wireless technology that remotely monitors patients’ implanted cardiac devices. The transmitter supports the St. Jude Medical Current® RF and Promote® RF family of devices and works in conjunction with the St. Jude Medical data management system, Merlin™.net Patient Care Network (PCN), to provide complete remote care service for patients and their physicians.
Until recently, patients with implanted cardiac devices were typically required to visit doctors’ offices several times per year to have their device performance checked. With the advent of transmitters capable of downloading and transmitting device data over telephone lines, patients are now able to initiate and perform many of these follow-ups in their own homes.
The Merlin@home transmitter’s wireless technology gives patients the additional comfort of having devices automatically checked. Since the transmitter initiates the scheduled follow-up and uses RF wireless telemetry to download data from the device, the entire follow-up procedure is conducted without any direct patient involvement. The only requirement is that each patient remains within range of the transmitter while it reads his or her device. Patients also may initiate data transmissions as instructed by their physicians.
The Merlin@home transmitter is transportable and can be set-up wherever a standard phone line is available, typically by the bedside for data transmission while the patient sleeps. Data downloaded by the Merlin@home transmitter is sent to Merlin.net PCN, a secure, Internet-based data management system, where it is stored for review by the patient’s physician. Adobe cc master collection mac os x crack included mega.
“We have simplified remote follow-ups to the extent that they are now something that can be performed seamlessly without interrupting the patient’s day. Patients simply set-up the Merlin@home transmitter; after that, the system handles all aspects of patient follow up, including daily monitoring,” said Eric S. Fain, M.D., president of the St. Jude Medical Cardiac Rhythm Management Division. “The simplicity of the system reduces the chance of patients missing follow-up transmissions.”
Merlin Home Transmitter Cost
The Merlin@home transmitter also monitors cardiac devices outside of regularly scheduled follow-ups. The system can perform daily checks to monitor for alerts about device performance or about patient heart rhythms that may have been detected by the implanted device. Merlin.net PCN can be programmed to alert a physician directly – including an on-call physician outside normal business hours – in the event that the monitored data reveals an episode the physician needs to know about as soon as possible.
“By directly alerting physicians, the Merlin@home transmitter and Merlin.net PCN can help reduce risks associated with cardiac episodes that physicians would want to know about right away,” said Fain. “Without this notification, these events might go undetected for significant amounts of time. Direct notification is one more way to give physicians more control over their patient’s critical health care.”
The Merlin@home transmitter will be available in the U.S. early this fall and internationally in the fourth quarter.
About Merlin.Net Patient Care Network (PCN)
Implantable cardiac devices are designed to capture and record vast amounts of information about device performance and patient heart rhythms that is vital to patient care. Merlin.net PCN not only stores this information for physicians to review, but also allows data to be sent directly to a clinic's or a hospital's electronic health records (EHR) system so the data is included in the patient’s comprehensive personal health record. With immediate access to patient information through the secure Merlin.net PCN website, physicians can remotely monitor and assess patient device data and determine the level of care needed. Alert notification delivery times can be customized by the physician.
Other Merlin.net PCN features include DirectCall™ Message, which uses an interactive voice recognition (IVR) system to call patients to remind them of upcoming scheduled follow-ups, inform them if they have missed a follow-up, confirm that their transmitted data has been reviewed or ask them to call their physician’s office for more information.
Merlin Home Transmitter 1150
Merlin.net PCN supports all currently marketed Atlas® and Epic® implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT-D) devices in the U.S, as well as Current® RF and Promote® RF devices. The Merlin.net PCN system adheres to patient privacy standards and requirements for the electronic transmission of health information, as set forth by the Health Insurance Portability and Accountability Act of 1996 (HIPAA).
About St. Jude Medical and Connectivity
St. Jude Medical is the only cardiac rhythm management company able to transfer information directly from the remote care system to a patient’s electronic health record using the requirements established by the IHE (Integrating the Healthcare Enterprise), which promotes standards for securely sharing healthcare information across clinical settings. Meeting these standards helps make the transfer of patient data from Merlin.net PCN to the clinic’s electronic health record (EHR) system seamless and secure.
About St. Jude Medical
Merlin Home Transmitter Model Ex1150
St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. Headquartered in St. Paul, Minn., St. Jude Medical employs more than 12,500 people worldwide and has five major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiac surgery, cardiology and neuromodulation. For more information, please visit www.sjm.com.
Forward-Looking Statements
Merlin Home Transmitter
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such forward-looking statements include the expectations, plans and prospects for the Company, including potential clinical successes, anticipated regulatory approvals and future product launches, and projected revenues, margins, earnings, and market shares. The statements made by the Company are based upon management’s current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include market conditions and other factors beyond the Company’s control and the risk factors and other cautionary statements described in the Company’s filings with the SEC, including those described in the Risk Factors and Cautionary Statements sections of the Company’s Annual Report on Form 10-K filed on February 27, 2008. The Company does not intend to update these statements and undertakes no duty to any person to provide any such update under any circumstance.